Some respiratory viruses, especially RSV, are seeing a late winter to early spring surge in Wisconsin, public health experts ...

Chronic hepatitis D coinfection affects an estimated 12 million people globally, with higher prevalence in low-income and middle-income countries, especially the African and Western Pacific regions.

People with MS have persistently high levels of EBV antibodies, a study found, pointing to a way to distinguish MS from ...

An antibody test for the infectious disease mpox was successfully developed during the new clade 1b outbreak in Rwanda, the ...

ALZpath, Inc., a leader in blood test-based diagnostic solutions for Alzheimer's disease, today announced the use of its proprietary pTau217 antibody across 29 presentations at the 2026 International ...

Monoclonal antibodies are among the most widely used biologic medicines, with applications ranging from cancer treatment to ...

Researchers from Indian Institute of Science Education and Research (IISER) Mohali have discovered that unique antibodies ...

TOKYO: The cumulative number of measles cases in Tokyo since January has reached 34, equaling last year's total, the Tokyo metropolitan government announced on Tuesday (March 17).

An antibody test for the infectious disease Mpox was successfully developed during the new clade 1b outbreak in Rwanda, the first time that an assay of its kind has been validated within this setting.

Almost all AAV cases were diagnosed in individuals with high pretest probability, including those with renal disease, peripheral neuropathies, or pulmonary infiltrates.

The very first patient would receive the first clinical doses of HMBD-001, the first cancer treatment from Hummingbird Bioscience. Piers Ingram, the cofounder and CEO of the company, was nervous, but ...

In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...